Copyright Reports & Markets. All rights reserved.

Global Lancets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Lancets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Safety Lancets
    • 1.3.3 Ordinary Lancets
  • 1.4 Market Analysis By End Users
    • 1.4.1 Overview: Global Lancets Consumption Value By End Users: 2021 Versus 2025 Versus 2032
    • 1.4.2 Diabetes Care
    • 1.4.3 Hospital Use
    • 1.4.4 Home Testing
  • 1.5 Market Analysis by Depth Control
    • 1.5.1 Overview: Global Lancets Consumption Value by Depth Control: 2021 Versus 2025 Versus 2032
    • 1.5.2 Fixed Depth
    • 1.5.3 Adjustable Depth
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Lancets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Blood Glucose Test
    • 1.6.3 Newborn Screening
    • 1.6.4 Rapid Blood Test
    • 1.6.5 Other
  • 1.7 Global Lancets Market Size & Forecast
    • 1.7.1 Global Lancets Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Lancets Sales Quantity (2021-2032)
    • 1.7.3 Global Lancets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Lancets Product and Services
    • 2.1.4 Roche Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Roche Recent Developments/Updates
  • 2.2 Lifescan
    • 2.2.1 Lifescan Details
    • 2.2.2 Lifescan Major Business
    • 2.2.3 Lifescan Lancets Product and Services
    • 2.2.4 Lifescan Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Lifescan Recent Developments/Updates
  • 2.3 BD
    • 2.3.1 BD Details
    • 2.3.2 BD Major Business
    • 2.3.3 BD Lancets Product and Services
    • 2.3.4 BD Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 BD Recent Developments/Updates
  • 2.4 MTD Group
    • 2.4.1 MTD Group Details
    • 2.4.2 MTD Group Major Business
    • 2.4.3 MTD Group Lancets Product and Services
    • 2.4.4 MTD Group Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 MTD Group Recent Developments/Updates
  • 2.5 Greiner Bio One
    • 2.5.1 Greiner Bio One Details
    • 2.5.2 Greiner Bio One Major Business
    • 2.5.3 Greiner Bio One Lancets Product and Services
    • 2.5.4 Greiner Bio One Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Greiner Bio One Recent Developments/Updates
  • 2.6 Owen Mumford
    • 2.6.1 Owen Mumford Details
    • 2.6.2 Owen Mumford Major Business
    • 2.6.3 Owen Mumford Lancets Product and Services
    • 2.6.4 Owen Mumford Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Owen Mumford Recent Developments/Updates
  • 2.7 Cardinal Health
    • 2.7.1 Cardinal Health Details
    • 2.7.2 Cardinal Health Major Business
    • 2.7.3 Cardinal Health Lancets Product and Services
    • 2.7.4 Cardinal Health Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Cardinal Health Recent Developments/Updates
  • 2.8 Ascensia
    • 2.8.1 Ascensia Details
    • 2.8.2 Ascensia Major Business
    • 2.8.3 Ascensia Lancets Product and Services
    • 2.8.4 Ascensia Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Ascensia Recent Developments/Updates
  • 2.9 Abbott
    • 2.9.1 Abbott Details
    • 2.9.2 Abbott Major Business
    • 2.9.3 Abbott Lancets Product and Services
    • 2.9.4 Abbott Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Abbott Recent Developments/Updates
  • 2.10 B. Braun
    • 2.10.1 B. Braun Details
    • 2.10.2 B. Braun Major Business
    • 2.10.3 B. Braun Lancets Product and Services
    • 2.10.4 B. Braun Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 B. Braun Recent Developments/Updates
  • 2.11 Terumo
    • 2.11.1 Terumo Details
    • 2.11.2 Terumo Major Business
    • 2.11.3 Terumo Lancets Product and Services
    • 2.11.4 Terumo Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Terumo Recent Developments/Updates
  • 2.12 I-SENS
    • 2.12.1 I-SENS Details
    • 2.12.2 I-SENS Major Business
    • 2.12.3 I-SENS Lancets Product and Services
    • 2.12.4 I-SENS Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 I-SENS Recent Developments/Updates
  • 2.13 Nipro
    • 2.13.1 Nipro Details
    • 2.13.2 Nipro Major Business
    • 2.13.3 Nipro Lancets Product and Services
    • 2.13.4 Nipro Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Nipro Recent Developments/Updates
  • 2.14 ICU Medical
    • 2.14.1 ICU Medical Details
    • 2.14.2 ICU Medical Major Business
    • 2.14.3 ICU Medical Lancets Product and Services
    • 2.14.4 ICU Medical Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 ICU Medical Recent Developments/Updates
  • 2.15 Sarstedt
    • 2.15.1 Sarstedt Details
    • 2.15.2 Sarstedt Major Business
    • 2.15.3 Sarstedt Lancets Product and Services
    • 2.15.4 Sarstedt Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Sarstedt Recent Developments/Updates
  • 2.16 Sinocare
    • 2.16.1 Sinocare Details
    • 2.16.2 Sinocare Major Business
    • 2.16.3 Sinocare Lancets Product and Services
    • 2.16.4 Sinocare Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Sinocare Recent Developments/Updates
  • 2.17 Yueyue Medical
    • 2.17.1 Yueyue Medical Details
    • 2.17.2 Yueyue Medical Major Business
    • 2.17.3 Yueyue Medical Lancets Product and Services
    • 2.17.4 Yueyue Medical Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Yueyue Medical Recent Developments/Updates
  • 2.18 Tianjin Huahong Medical
    • 2.18.1 Tianjin Huahong Medical Details
    • 2.18.2 Tianjin Huahong Medical Major Business
    • 2.18.3 Tianjin Huahong Medical Lancets Product and Services
    • 2.18.4 Tianjin Huahong Medical Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Tianjin Huahong Medical Recent Developments/Updates
  • 2.19 Suzhou Shilai Medical
    • 2.19.1 Suzhou Shilai Medical Details
    • 2.19.2 Suzhou Shilai Medical Major Business
    • 2.19.3 Suzhou Shilai Medical Lancets Product and Services
    • 2.19.4 Suzhou Shilai Medical Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Suzhou Shilai Medical Recent Developments/Updates
  • 2.20 Shandong Lianfa Medical
    • 2.20.1 Shandong Lianfa Medical Details
    • 2.20.2 Shandong Lianfa Medical Major Business
    • 2.20.3 Shandong Lianfa Medical Lancets Product and Services
    • 2.20.4 Shandong Lianfa Medical Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Shandong Lianfa Medical Recent Developments/Updates
  • 2.21 Promisemed
    • 2.21.1 Promisemed Details
    • 2.21.2 Promisemed Major Business
    • 2.21.3 Promisemed Lancets Product and Services
    • 2.21.4 Promisemed Lancets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.21.5 Promisemed Recent Developments/Updates

3 Competitive Environment: Lancets by Manufacturer

  • 3.1 Global Lancets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Lancets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Lancets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Lancets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Lancets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Lancets Manufacturer Market Share in 2025
  • 3.5 Lancets Market: Overall Company Footprint Analysis
    • 3.5.1 Lancets Market: Region Footprint
    • 3.5.2 Lancets Market: Company Product Type Footprint
    • 3.5.3 Lancets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Lancets Market Size by Region
    • 4.1.1 Global Lancets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Lancets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Lancets Average Price by Region (2021-2032)
  • 4.2 North America Lancets Consumption Value (2021-2032)
  • 4.3 Europe Lancets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Lancets Consumption Value (2021-2032)
  • 4.5 South America Lancets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Lancets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Lancets Sales Quantity by Type (2021-2032)
  • 5.2 Global Lancets Consumption Value by Type (2021-2032)
  • 5.3 Global Lancets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Lancets Sales Quantity by Application (2021-2032)
  • 6.2 Global Lancets Consumption Value by Application (2021-2032)
  • 6.3 Global Lancets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Lancets Sales Quantity by Type (2021-2032)
  • 7.2 North America Lancets Sales Quantity by Application (2021-2032)
  • 7.3 North America Lancets Market Size by Country
    • 7.3.1 North America Lancets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Lancets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Lancets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Lancets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Lancets Market Size by Country
    • 8.3.1 Europe Lancets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Lancets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Lancets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Lancets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Lancets Market Size by Region
    • 9.3.1 Asia-Pacific Lancets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Lancets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Lancets Sales Quantity by Type (2021-2032)
  • 10.2 South America Lancets Sales Quantity by Application (2021-2032)
  • 10.3 South America Lancets Market Size by Country
    • 10.3.1 South America Lancets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Lancets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Lancets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Lancets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Lancets Market Size by Country
    • 11.3.1 Middle East & Africa Lancets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Lancets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Lancets Market Drivers
  • 12.2 Lancets Market Restraints
  • 12.3 Lancets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Lancets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Lancets
  • 13.3 Lancets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Lancets Typical Distributors
  • 14.3 Lancets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Lancets market size was valued at US$ 1773 million in 2025 and is forecast to a readjusted size of US$ 2164 million by 2032 with a CAGR of 2.9% during review period.
    Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. Lancets are designed to only be used once, and then disposed of in a safe way. These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.In 2025, global Lancets production reached approximately 57.01 billion units, with an average global market price of around 30.22 US$ / k unit.
    Market Drivers:
    Growing prevalence of chronic diseases: The rise in chronic conditions like diabetes, which require regular blood glucose monitoring, is a significant driver for lancet demand. As the number of diabetes patients increases globally, the need for lancets continues to grow.
    Technological advancements in lancets: Innovations such as ultra-thin needles, painless lancet designs, and easy-to-use lancet devices improve user experience, making blood sampling more comfortable and encouraging more frequent use.
    Increase in home-based healthcare: The trend toward home healthcare and self-monitoring for various conditions, especially diabetes, has driven the use of lancets. This allows patients to monitor their health in a more convenient and cost-effective way, increasing the market for these devices.
    Aging population: The growing elderly population is more prone to chronic diseases like diabetes, requiring regular blood monitoring. This demographic shift is a major factor pushing the demand for lancets and other monitoring devices.
    Rising awareness of preventive healthcare: Increasing awareness of the importance of regular health monitoring, especially for managing conditions like diabetes, has led to higher adoption of lancets for routine blood tests and glucose monitoring.
    Market Challenges:
    Competition from alternative technologies: Non-invasive blood glucose monitoring methods (such as continuous glucose monitors or sensor-based systems) are gaining traction, potentially reducing the reliance on traditional lancets for blood sampling.
    High recurring costs for patients: Lancets are single-use devices, and the recurring cost for people who need frequent testing can become a financial burden, particularly in low-income regions or for uninsured patients, limiting market growth.
    Infection risks: Improper or repeated use of lancets can lead to infections, particularly if they are not disposed of properly or if reused by mistake, which poses a health risk and deters their use.
    Environmental concerns: Lancets contribute to medical waste, as they are disposable devices, raising concerns about environmental impact. This could lead to regulatory pressures or a shift toward more sustainable alternatives.
    Regulatory compliance and approval hurdles: The lancet market is subject to stringent regulations and approval processes from health authorities. This can slow down the introduction of new products and innovations, delaying their availability in the market.
    This report is a detailed and comprehensive analysis for global Lancets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Lancets market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
    Global Lancets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
    Global Lancets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
    Global Lancets market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Lancets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Lancets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Lifescan, BD, MTD Group, Greiner Bio One, Owen Mumford, Cardinal Health, Ascensia, Abbott, B. Braun, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Lancets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Safety Lancets
    Ordinary Lancets
    Market segment By End Users
    Diabetes Care
    Hospital Use
    Home Testing
    Market segment by Depth Control
    Fixed Depth
    Adjustable Depth
    Market segment by Application
    Blood Glucose Test
    Newborn Screening
    Rapid Blood Test
    Other
    Major players covered
    Roche
    Lifescan
    BD
    MTD Group
    Greiner Bio One
    Owen Mumford
    Cardinal Health
    Ascensia
    Abbott
    B. Braun
    Terumo
    I-SENS
    Nipro
    ICU Medical
    Sarstedt
    Sinocare
    Yueyue Medical
    Tianjin Huahong Medical
    Suzhou Shilai Medical
    Shandong Lianfa Medical
    Promisemed
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Lancets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Lancets, with price, sales quantity, revenue, and global market share of Lancets from 2021 to 2026.
    Chapter 3, the Lancets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Lancets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Lancets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Lancets.
    Chapter 14 and 15, to describe Lancets sales channel, distributors, customers, research findings and conclusion.

    Buy now